Antifibrinolytics in liver transplantation.

Int Anesthesiol Clin

Department of Anesthesiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Published: August 2006

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aia.0000210804.39545.66DOI Listing

Publication Analysis

Top Keywords

antifibrinolytics liver
4
liver transplantation
4
antifibrinolytics
1
transplantation
1

Similar Publications

Background: During orthotopic liver transplantation, allograft reperfusion is a dynamic point in the operation and often requires vasoactive medications and blood transfusions. Normothermic machine perfusion (NMP) of liver allografts has emerged to increase the number of transplantable organs and may have utility during donation after circulatory death (DCD) liver transplantation in reducing transfusion burden and vasoactive medication requirements.

Methods: This is a single-center retrospective study involving 226 DCD liver transplant recipients who received an allograft transported with NMP (DCD-NMP group) or with static cold storage (DCD-SCS group).

View Article and Find Full Text PDF

Introduction: The transition to or from direct oral anticoagulants (DOACs) is common in clinical practice.

Areas Covered: A literature search was conducted on PubMed, Google Scholar, and UpToDate up to March 2024 for conditions and approaches for transitioning from one agent to the other. No randomized clinical trials were retrieved except for two studies regarding switching to DOAC in well-conducted vitamin K antagonist (VKA) therapy.

View Article and Find Full Text PDF

EVALUATION OF PROTEIN C AND S IN Β-THALASSEMIA MAJOR.

Georgian Med News

October 2024

2College of Medicine, University of Mosul, Iraq.

Unlabelled: Beta-thalassemia major is a genetic disease characterized by formation of little or no beta-globin chain, leading to premature death of red blood cells and hence to ineffective erythropoiesis. Aim of this study to evaluate Protein C and Protein S in patient with beta-thalassemia major and its correlation with haemoglobin, serum ferritin, D. dimer, prothrombin time and liver enzymes.

View Article and Find Full Text PDF

Patient sex and use of tranexamic acid in liver transplantation.

Front Med (Lausanne)

September 2024

Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany.

Background: Differences in medical treatment between women and men are common and involve out-of-hospital emergency care, the intensity of pain treatment, and the use of antifibrinolytic treatment in emergency trauma patients. If woman and man receive different antifibrinolytic treatment in highly-standardized major transplant surgery is unknown.

Methods: We conducted a retrospective cohort study on patients who underwent liver transplantation at Heidelberg University Hospital, Heidelberg, Germany between 2004 and 2017.

View Article and Find Full Text PDF

Prospective cohort study of rotational thromboelastometry in established biliary obstruction: dispelling the myth of auto-anticoagulation.

HPB (Oxford)

December 2024

Department of General Surgical Specialties, The Royal Melbourne Hospital, Melbourne, VIC 3052, Australia; The University of Melbourne, Melbourne, VIC 3052, Australia; Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia; Department of Surgery, University of Auckland, Auckland, New Zealand.

Article Synopsis
  • This study looked at patients with obstructive jaundice to check their blood clotting ability using a special test called ROTEM.
  • They found that most patients had normal or very strong blood clotting rather than weak clotting, which is what doctors used to think.
  • This means the idea that people with obstructive jaundice have weak blood clotting might not be true, especially since many had cancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!